Thousands of Australians with osteoporosis will now have access to a game-changing and affordable treatment after the drug Evenity was added to the Pharmaceutical Benefits Scheme.
An analysis of pancreatic cancer data in younger adults found that while there is an increasing incidence of pancreatic cancer in young adults, the mortality rate remains stable.
A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...